Clinical Trial Update: Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MB07803 for safety, tolerability, and efficacy in type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MB07803

Snippet

Sponsor: Ligand Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED